Abiopharma

🔍 Silvernail Andrew K (Director)

Company: STRYKER CORP (SYK)

Report Date: 2026-05-06

Detailed Transactions and Holdings:

• Acquired 762 shares of Common Stock (Direct)
  Date: 2026-05-06 | Code: A | equity_swap_involved: 0 | shares_owned_after: 18,465.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents a grant of Restricted Stock Units (RSUs), which vest as to 100% of the shares on the earlier of (i) the date of the 2027 Annual Meeting of Shareholders of Stryker Corporation or (ii) May 6, 2027. The Reporting Person voluntarily elected to defer receipt of the shares of Stryker Common Stock issuable upon settlement of the RSUs until his departure from the Board of Directors.
• F2: Each RSU represents a contingent right to receive one share of Stryker Common Stock.